L1 Capital Global Opportunities Master Fund, Ltd. 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-23 4:08 pm Purchase |
2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO |
L1 Capital Global Opportunities Master Fund, Ltd. | 285,000 9.950% |
265,000 (+1325.00%) |
Filing |
| 2025-06-23 4:07 pm Purchase |
2025-04-26 | 13G | Aptevo Therapeutics Inc. APVO |
L1 Capital Global Opportunities Master Fund, Ltd. | 20,000 0.700% |
20,000 (New Position) |
Filing |